Who we are
A Boston investment bank, founded in 1992, that advises founders, families and management teams of consumer and healthcare companies on sales, acquisitions, financings and valuations.
Since 1992, Tully & Holland has focused on serving consumer businesses, and today advises consumer and healthcare companies across six sectors. The firm was founded by partners who combined investment banking with operating experience, and that pairing still defines us: our financial expertise, together with deep industry experience, lets us understand what our clients are trying to achieve.
What sets us apart
Operators first
Our bankers held senior roles in leading consumer, healthcare and retail companies before they advised on them, including H.J. Heinz, RJR Nabisco, Ocean Spray, Gorton’s, Kraft, Diageo, Thermo Fisher Scientific, P&G and Bristol Myers Squibb. We read a business the way a buyer will.
Senior attention on every deal
The senior team is involved in every phase of a transaction. The people you meet first are the people who negotiate your deal, from the first conversation to the close.
Specialized and independent
We have stayed concentrated on consumer and healthcare for more than three decades, and independent throughout, so our advice carries no agenda beyond your outcome.
Brand & financial experience
Before Tully & Holland, our bankers built and sold brands inside some of the largest consumer and healthcare companies in the country, and ran deals at the banks and funds on the other side of the table. That operator lens is what clients hire us for.
Nabisco
Heinz
Diageo
Ocean Spray
Gorton’s
P&G
Thermo Fisher Scientific
Bristol Myers Squibb
William Blair
Citi
Winona Capital
Webster Equity Partners
Articles & Insights

Snack Food Industry Update October 2026
US snack sales grew about 4.8% to roughly $156 billion, and almost none of it came from volume. The companies winning no...
Read →
Women's Health Industry Update October 2026
A category that lived in three different aisles is becoming a destination, and strategic acquirers have moved with it. D...
Read →
Beverage Industry Update Q2 2026
The strategics have stopped waiting for internal innovation to catch the growth brands. From PepsiCo's $1.95 billion pur...
Read →
Biotech Update Q2 2026
Biotech capital invested more than doubled quarter over quarter to $133.2 billion, biopharma M&A ran at $55.1 billion in...
Read →
Consumer Industry Update Q2 2026
Consumer median deal values set a twelve-quarter record and healthcare multiples touched a twenty-year high, while spons...
Read →
Consumer Industry Update Q1 2026
Global deal value set an all-time record while capital crowded into a handful of megadeals, and healthcare capital inves...
Read →
Pet Industry Update January 2026
Revenue has grown more than 70% since 2018, and buyers are paying up for the businesses built on recurring care. Our 202...
Read →
Consumer Industry Update Q4 2025
Global M&A closed 2025 at nearly $5 trillion, the strongest year for dealmaking on record, and the fourth quarter set a ...
Read →